These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 8706031
21. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Oguey D, Dumenco LL, Pierce RH, Fausto N. Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370 [Abstract] [Full Text] [Related]
22. Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Peng Z, Zhang Y, Gu W, Wang Z, Li D, Zhang F, Qiu G, Xie K. Int J Oncol; 2005 Feb; 26(2):467-73. PubMed ID: 15645132 [Abstract] [Full Text] [Related]
23. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. Zhang X, Dong N, Zhang H, You J, Wang H, Ye L. J Lab Clin Med; 2005 Feb; 145(2):98-104. PubMed ID: 15746653 [Abstract] [Full Text] [Related]
24. Effect of hepatitis B virus X protein on the expression of retinoblastoma gene product. Farshid M, Nedjar S, Mitchell F, Biswas R. Acta Virol; 1997 Jun; 41(3):125-9. PubMed ID: 9385399 [Abstract] [Full Text] [Related]
25. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. d'Arville CN, Nouri-Aria KT, Johnson P, Williams R. Hepatology; 1991 Feb; 13(2):310-5. PubMed ID: 1847351 [Abstract] [Full Text] [Related]
26. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H, Gao L, Chai N, Song J, Wang J, Song Z, Chen C, Pan Y, Zhao L, Sun S, Wu K, Feitelson MA, Liu J, Fan D. Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [Abstract] [Full Text] [Related]
27. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF. Oncogene; 2000 Nov 02; 19(46):5213-20. PubMed ID: 11077437 [Abstract] [Full Text] [Related]
28. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Bae SK, Bae MH, Ahn MY, Son MJ, Lee YM, Bae MK, Lee OH, Park BC, Kim KW. Cancer Res; 1999 Dec 01; 59(23):5989-94. PubMed ID: 10606246 [Abstract] [Full Text] [Related]
29. Insulin-like growth factor 1 receptors are increased in estrogen-induced kidney tumors. Narayan S, Roy D. Cancer Res; 1993 May 15; 53(10 Suppl):2256-9. PubMed ID: 8485711 [Abstract] [Full Text] [Related]
30. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY. Clin Cancer Res; 2008 Aug 15; 14(16):5061-8. PubMed ID: 18698024 [Abstract] [Full Text] [Related]
31. [Induction of SMYD3 by hepatitis B virus X gene in HepG2 cells]. Yang L, Ren J, He J, Chen LB. Zhonghua Gan Zang Bing Za Zhi; 2009 Apr 15; 17(4):297-300. PubMed ID: 19403031 [Abstract] [Full Text] [Related]
32. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Lee Y, Park US, Choi I, Yoon SK, Park YM, Lee YI. Clin Cancer Res; 1998 Jul 15; 4(7):1711-7. PubMed ID: 9676846 [Abstract] [Full Text] [Related]
33. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH, Lee YS, Jang KL, Kim CH, Johnston RN, Chung YH. Cancer Gene Ther; 2009 May 15; 16(5):453-61. PubMed ID: 19096445 [Abstract] [Full Text] [Related]
34. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA]. Ma CH, Sun WS, Liu SX, Wang XY, Zhang LN, Cao YL, Han LH. Zhonghua Gan Zang Bing Za Zhi; 2003 May 15; 11(5):291-4. PubMed ID: 12773245 [Abstract] [Full Text] [Related]
35. Identification of a natural mutant of HBV X protein truncated 27 amino acids at the COOH terminal and its effect on liver cell proliferation. Zhang H, Shan CL, Li N, Zhang X, Zhang XZ, Xu FQ, Zhang S, Qiu LY, Ye LH, Zhang XD. Acta Pharmacol Sin; 2008 Apr 15; 29(4):473-80. PubMed ID: 18358094 [Abstract] [Full Text] [Related]
36. HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development. Severi T, Vander Borght S, Libbrecht L, VanAelst L, Nevens F, Roskams T, Cassiman D, Fevery J, Verslype C, van Pelt JF. Chem Biol Interact; 2007 Jun 30; 168(2):128-34. PubMed ID: 17482587 [Abstract] [Full Text] [Related]
37. Repression of hepatitis B virus X gene expression by hammerhead ribozymes. Kim YK, Junn E, Park I, Lee Y, Kang C, Ahn JK. Biochem Biophys Res Commun; 1999 Apr 21; 257(3):759-65. PubMed ID: 10208856 [Abstract] [Full Text] [Related]
38. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S. Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152 [Abstract] [Full Text] [Related]
39. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C. Oncogene; 1999 Aug 26; 18(34):4848-59. PubMed ID: 10490818 [Abstract] [Full Text] [Related]
40. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression. Kim SY, Kim JK, Kim HJ, Ahn JK. IUBMB Life; 2005 Sep 26; 57(9):651-8. PubMed ID: 16203685 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]